|
BEND3 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | <1E-12 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.09277040141842E-12 |
| Normal-vs-Stage2 |
2.08755235320268E-12 |
| Normal-vs-Stage3 |
5.24025267623074E-14 |
| Normal-vs-Stage4 |
3.69570000158248E-08 |
| Stage1-vs-Stage2 |
3.630400E-02 |
| Stage1-vs-Stage3 |
7.586200E-02 |
| Stage1-vs-Stage4 |
8.078800E-01 |
| Stage2-vs-Stage3 |
4.573600E-01 |
| Stage2-vs-Stage4 |
1.872430E-01 |
| Stage3-vs-Stage4 |
3.770800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.66333613549341E-12 |
| Normal-vs-AfricanAmerican |
6.595300E-03 |
| Normal-vs-Asian |
1.594020E-01 |
| Caucasian-vs-AfricanAmerican |
1.147360E-01 |
| Caucasian-vs-Asian |
4.413600E-02 |
| AfricanAmerican-vs-Asian |
5.035400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.63913327355658E-12 |
| Normal-vs-Female |
2.97969999785153E-08 |
| Male-vs-Female |
1.641760E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.473200E-01 |
| Normal-vs-Age(41-60Yrs) |
1.62558855265615E-12 |
| Normal-vs-Age(61-80Yrs) |
1.87116988570324E-12 |
| Normal-vs-Age(81-100Yrs) |
1.10379999584964E-08 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.647000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.533200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.964000E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.835400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.166640E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.358000E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
3.401100E-03 |
| Normal-vs-Grade 2 |
9.77580238981091E-11 |
| Normal-vs-Grade 3 |
1.62458935193399E-12 |
| Normal-vs-Grade 4 |
3.45610207119762E-11 |
| Grade 1-vs-Grade 2 |
7.296600E-01 |
| Grade 1-vs-Grade 3 |
2.087400E-01 |
| Grade 1-vs-Grade 4 |
3.827400E-01 |
| Grade 2-vs-Grade 3 |
2.948500E-02 |
| Grade 2-vs-Grade 4 |
3.590000E-01 |
| Grade 3-vs-Grade 4 |
4.091400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
5.10702591327572E-15 |
| Normal-vs-ccB subtype |
1.17459999948721E-07 |
| ccA subtype-vs-ccB subtype |
4.345000E-03 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.09219316818599E-12 |
| Normal-vs-N1 |
7.970000E-04 |
| N0-vs-N1 |
8.033400E-01 |
|
|
